SCHEMBL367348

SCHEMBL367348

CS(=O)(=O)NC(=O)c1ccc(OCc2cc(Cl)cc(Cl)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 5/20 0.57
MCL1 Q07820 5/20 0.57
SCN9A Q15858 4/20 0.53
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
RXRA P19793 1/20 0.48
RXRB P28702 1/20 0.48
RXRG P48443 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.47
SCN3A Q9NY46 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
KMT2A Q03164 1/20 0.47
SENP8 Q96LD8 1/20 0.47
SENP7 Q9BQF6 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL365474 0.89 MAOB (0.67) BCL2L1MCL1MAOAMAOBRXRA
SCHEMBL365210 0.88 MAOA (0.63) BCL2L1MCL1SCN9AMAOAMAOB
SCHEMBL366081 0.88 MAOA (0.63) BCL2L1MCL1SCN9AMAOAMAOB
SCHEMBL10203178 0.85 SCN9A (0.66) BCL2L1MCL1SCN9AMAOAMAOB
SCHEMBL14890621 0.84 GSK3B (0.55) BCL2L1MCL1SCN9AMAOBSCN3A
Diethylamine SCHEMBL16239880 0.83 MAOA (0.56) BCL2L1MCL1SCN9AMAOAMAOB
SCHEMBL365173 0.82 MAOB (0.61) BCL2L1MCL1MAOBSCN3AMEN1
SCHEMBL364950 0.82 MAOB (0.66) BCL2L1MCL1SCN9AMAOAMAOB
SCHEMBL16240196 0.82 SCN9A (0.77) BCL2L1MCL1SCN9AMRGPRX4ALDH1A1
SCHEMBL365348 0.82 SCN9A (0.56) BCL2L1MCL1SCN9AMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096500-B2 Acyl sulfonamide compounds PFIZER LIMITED (GB) 2015-08-04 US disclosed
EP-2593428-B1 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS PFIZER LTD (GB) 2014-11-19 EP disclosed
EP-2593428-A2 N-SULFONYLBENZAMIDES AS INHIBITORS OF VOLTAGE-GATED SODIUM CHANNELS Pfizer Limited (GB) 2013-05-22 EP disclosed
US-20130109701-A1 Chemical Compounds PFIZER LIMITED (GB) 2013-05-02 US disclosed
WO-2012007868-A2 CHEMICAL COMPOUNDS PFIZER LIMITED (GB) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130109701-A1 Chemical Compounds SCN1A, SCN1B, SCN7A BCL2L1 3577/4885MCL1 2841/4885SCN9A 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.